NC for this post
i work in a corporate vet chain. There is a lot of work and targets involved in reducing antibiotic use (due to the massive risk of antimicrobial resistance globally), which is important and to be applauded. The rcvs/vmd have classified anti-parasite treatment in the same category as antibiotics when it comes to prescribing controls. Unfortunately the corporates have not been so hot in trying to reduce/target anti parasite use because of client demand and it is the backbone of health care plans and subscriptions. I would love to see egg counts on the plans instead of blanket worming for example.
For years there has also been a lot of fearmongering about lungworm, which is dangerous to dogs but also rare, plus the human health risks from toxocara which does still cause around 7-10 children to go blind annually in the U.K.
Lastly, the regulation of over the counter flea and worm products is really poor so targeting veterinary prescribed parasite treatments while not tackling these older and often higher volume products is not a full solution.
I personally think it needs to be government mandated change, involving public education, because most clients want blanket prevention of parasites and the finance model of many practices would need to fundamentally change if this income stream was discontinued. Clients would still buy the products they want online so it wouldn’t necessarily help without widespread public education.